50 Cases In Clinical Cardiology : A Problem Sol...
This book provides postgraduate trainees with 50 real clinical cardiology cases. Divided into fourteen sections, several cases are presented under each category covering various disorders of the cardiac system, including congenital heart diseases, aortic valve diseases, pulmonary diseases, ECG abnormalities, cardiac arrhythmias, coronary artery disease and much more. Beginning with a brief history and findings based on physical examination, each case then includes analytical discussion on bedside investigations and proposals for treatment. Authored by a recognised expert in the field, this practical book is highly illustrated with echocardiographic, radiographic and electrocardiographic data. Key points Presents 50 real clinical cardiology cases Covers numerous disorders of the cardiac system Authored by recognised cardiologist Includes more than 217 images, illustrations and tables
50 cases in clinical cardiology : a problem sol...
This book provides postgraduate trainees with 50 real clinical cardiology cases. Divided into fourteen sections, several cases are presented under each category covering various disorders of the cardiac system, including congenital heart diseases, aortic valve diseases, pulmonary diseases, ECG abnormalities, cardiac arrhythmias, coronary artery disease and much more. Beginning with a brief history and findings based on physical examination, each case then includes analytical discussion on bedside investigations and proposals for treatment. Authored by a recognised expert in the field, this practical book is highly illustrated with echocardiographic, radiographic and electrocardiographic data. Key points * Presents 50 real clinical cardiology cases * Covers numerous disorders of the cardiac system * Authored by recognised cardiologist * Includes more than 217 images, illustrations and tables.
This book, 50 Cases in Clinical Cardiology: A Problem Solving Approach, deals with cardiology. This is a compilation of real-world situations in clinical cardiology. Each case is introduced with a brief history and findings on physical examination. The clinical problem is then discussed and analytically solved with the aid of one or more simple bedside investigations. The case concludes with pertinent management issues along with some recent advancement in diagnostics and therapeutics pertaining to that clinical entity. The text is suitably complemented by impressive illustrations of ECG strips, chest X-rays and ECHO images. Students preparing for their examinations, resident doctors working in cardiac units and clinicians involved in heart care are bound to benefit from this book.
The US Food and Drug Administration (FDA) and European Medicines Agency have both issued warning statements listing DKA as a rare adverse reaction of SGLT-2-inhibitor treatment. In clinical trials of patients with type 1 diabetes treated with SGLT-2 inhibitors, about 10% of patients developed ketosis and 5-6% required hospitalization for DKA. In patients with type 2 diabetes, DKA is rare, reported in 0.1-0.8 per 1,000 patients. Most cases of DKA occur among patients with a concomitant precipitating cause, such as surgery, alcohol abuse, insulin pump malfunction, and poor adherence to medications. Awareness among healthcare professionals, as well as patient education, might facilitate early detection of DKA during SGLT-2 inhibitor treatment or even prevent development of this diabetes emergency.
Children and adults with NF1 can have a variety of symptoms and medical problems that can change across a lifespan. Most people with NF1 have an average life expectancy. Because many of the other clinical features of NF1 develop as an individual ages, getting the correct diagnosis may take several years.
Schwannomatosis (SWN) is the rarest form of the three conditions and is genetically and clinically distinct from NF1 and NF2. In many cases, mutation of the SMARCB or LZTR1 genes is associated with the disease; however, the genetic cause of SWN in some people is unknown.
Current basic and clinical research is not only aimed at understanding how genetic defects cause the diverse conditions and medical problems encountered people with NF, but also how to predict which clinical features will arise in any given person (personalized or precision medicine). In addition, studies in NF1, NF2, and SWN have revealed numerous important insights for investigators working in other fields, including brain cancer, sarcoma, autism, learning disabilities, nerve regeneration, chronic pain, and targeted therapies.
Several side effects have been described over time, especially in cases of chronic use. It is estimated that the prevalence of adverse effects related to treatment with amiodarone is 15% the first year and 50% in cases of prolonged administration. In addition, 20% of patients require discontinued therapy due to effects such as liver damage, problems with thyroid function and chronic pulmonary squeal, which have been described in up to 1% per year of treatment, with cumulative damage of between 5% and 10%. Lung damage is the best known: it is produced after long exposure to amiodarone (2.3), but there also have been reports of acute toxicity. Here are the most frequent, collateral effects of the drug:
Similarly, there is no method to distinguish cases of cancer caused by arsenic from cancers induced by other factors. As a result, there is no reliable estimate of the magnitude of the problem worldwide.
Nursing students face unique problems which are specific to the clinical and therapeutic environment, causing a lot of stresses during clinical education. This stress can affect their problem- solving skills [18,19,20,21]. They need to promote their problem-solving and critical thinking skills to meet the complex needs of current healthcare settings and should be able to respond to changing circumstances and apply knowledge and skills in different clinical situations . Institutions should provide this important opportunity for them.
Sonya G. Gordon, DVM, DVSc, DACVIM (Cardiology), is an associate professor of cardiology in the Department of Small Animal Clinical Sciences at Texas A&M University College of Veterinary Medicine and Biomedical Sciences where she is part of a busy progressive cardiology program. She is routinely an invited speaker at local, national and international veterinary meetings. Although she considers herself a clinician and teacher first her research interests include canine chronic valve disease, dilated cardiomyopathy, imaging, interventional procedures and clinical trials. She has published numerous manuscripts and book chapters and co-authored a practical small animal clinical cardiology book entitled The ABCDs of Small Animal Cardiology. 041b061a72